The “OCS 2021 Guangzhou Life and Health Innovative Talent Summit (hereinafter referred to as the “Summit”) hosted by Guangzhou Municipal Science and Technology Bureau and organized by Guangzhou Biotechnology Center Co., Ltd. was held on December 17. The Summit drew experts and scholars from home and abroad in the fields of vaccine R&D, R&D of medical device, Chinese medicine development, online medical care, etc.
The life and health industry has always been a strategic emerging industry for key development in Guangzhou.
The launching ceremony of Guangzhou program for high-quality development and cultivation of leading biomedicine companies was held during the Summit. With the support of Guangzhou Municipal Science and Technology Bureau, this program aims to serve as a platform of communication and learning for entrepreneurs in the life and health industry, improve the entrepreneur service system, and select, cultivate, and support leading entrepreneurs in the life and health industry who have an international perspective, strategic vision, and a sense of social responsibility and mission in light of the construction of the Guangdong-Hong Kong-Macao Greater Bay Area and the plan for important strategic emerging industries in Guangzhou.
Currently, Guangzhou has formed a pattern for the biomedicine industry, with “two cities and one island” as the center and “three centers and multiple regions” as the support. According to statistics, Guangzhou is home to over 5,500 biomedical companies, ranking among the top three in the country. In the field of biomedical patents, 42 applications for the registration of innovative drugs in Guangzhou were filed in 2020. In the field of medical devices, 382 class-2 and class-3 medical device products were approved in Guangzhou in 2020.